CA2085171C - Guanidinoalkyl-1, 1-bisphosphonic acid derivatives, process for their preparation and their use - Google Patents

Guanidinoalkyl-1, 1-bisphosphonic acid derivatives, process for their preparation and their use Download PDF

Info

Publication number
CA2085171C
CA2085171C CA002085171A CA2085171A CA2085171C CA 2085171 C CA2085171 C CA 2085171C CA 002085171 A CA002085171 A CA 002085171A CA 2085171 A CA2085171 A CA 2085171A CA 2085171 C CA2085171 C CA 2085171C
Authority
CA
Canada
Prior art keywords
compound
formula
hydrogen atom
alkyl
mono
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA002085171A
Other languages
English (en)
French (fr)
Other versions
CA2085171A1 (en
Inventor
Hans-Jochen Lang
Christoph Naumann
Denis Carniato
Anne-Marie Moura
Ryoichi Satoh
Masakazu Katoh
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst AG filed Critical Hoechst AG
Publication of CA2085171A1 publication Critical patent/CA2085171A1/en
Application granted granted Critical
Publication of CA2085171C publication Critical patent/CA2085171C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40—Esters thereof
    • C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4025—Esters of poly(thio)phosphonic acids
    • C07F9/405—Esters of poly(thio)phosphonic acids containing nitrogen substituent, e.g. N.....H or N-hydrocarbon group which can be substituted by halogen or nitro(so), N.....O, N.....S, N.....C(=X)- (X =O, S), N.....N, N...C(=X)...N (X =O, S)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/3804—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
    • C07F9/3839—Polyphosphonic acids
    • C07F9/3873—Polyphosphonic acids containing nitrogen substituent, e.g. N.....H or N-hydrocarbon group which can be substituted by halogen or nitro(so), N.....O, N.....S, N.....C(=X)- (X =O, S), N.....N, N...C(=X)...N (X =O, S)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
    • C07F9/6503—Five-membered rings
    • C07F9/6506—Five-membered rings having the nitrogen atoms in positions 1 and 3
    • C07F9/65068—Five-membered rings having the nitrogen atoms in positions 1 and 3 condensed with carbocyclic rings or carbocyclic ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CA002085171A 1991-12-12 1992-12-11 Guanidinoalkyl-1, 1-bisphosphonic acid derivatives, process for their preparation and their use Expired - Fee Related CA2085171C (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE4140908 1991-12-12
DEP4140908.6 1991-12-12
DE4211976 1992-04-09
DEP4211976.6 1992-04-09

Publications (2)

Publication Number Publication Date
CA2085171A1 CA2085171A1 (en) 1993-06-13
CA2085171C true CA2085171C (en) 2003-12-02

Family

ID=25910001

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002085171A Expired - Fee Related CA2085171C (en) 1991-12-12 1992-12-11 Guanidinoalkyl-1, 1-bisphosphonic acid derivatives, process for their preparation and their use

Country Status (16)

Country Link
US (1) US5294608A (enExample)
EP (1) EP0546548B1 (enExample)
JP (1) JP3377234B2 (enExample)
KR (1) KR100269544B1 (enExample)
AT (1) ATE152453T1 (enExample)
AU (1) AU657018B2 (enExample)
BR (1) BR9204984A (enExample)
CA (1) CA2085171C (enExample)
DE (1) DE59208426D1 (enExample)
DK (1) DK0546548T3 (enExample)
ES (1) ES2101012T3 (enExample)
FI (1) FI105550B (enExample)
MX (1) MX9207215A (enExample)
NZ (1) NZ245414A (enExample)
RU (1) RU2124519C1 (enExample)
TW (1) TW222637B (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8922026D0 (en) * 1989-09-29 1989-11-15 Pharma Mar Sa Novel anti-viral and cytotoxic agent
US20030148933A1 (en) * 1990-10-01 2003-08-07 Pharma Mar S.A. Derivatives of dehydrodidemnin B
DE4223940A1 (de) * 1992-07-21 1994-01-27 Boehringer Mannheim Gmbh Neue acyclische Amidingruppen-haltige Diphosphonsäurederivate, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
ES2129485T3 (es) * 1992-12-02 1999-06-16 Hoechst Ag Derivados de acidos guanidinoalquil-1,1-bisfosfonicos, procedimiento para su preparacion y su utilizacion.
JPH06298779A (ja) * 1993-04-15 1994-10-25 Hoechst Japan Ltd ヘテロ環イミノビスメチレンビスホスホン酸誘導体
US5854227A (en) * 1994-03-04 1998-12-29 Hartmann; John F. Therapeutic derivatives of diphosphonates
DE19546736A1 (de) * 1995-12-14 1997-06-19 Hoechst Ag Substituierte Chromanylsulfonyl(thio)harnstoffe, Verfahren zu ihrer Herstellung und ihre Verwendung zur Herstellung pharmazeutischer Präparate
DE69819311T2 (de) * 1997-03-07 2004-07-29 Metabasis Therapeutics Inc., San Diego Neue benzimidazol inhibitoren der fructose-1,6-bisphosphatase
WO1998039344A1 (en) * 1997-03-07 1998-09-11 Metabasis Therapeutics, Inc. Novel purine inhibitors of fructose-1,6-bisphosphatase
IT1303672B1 (it) 1998-07-28 2001-02-23 Nicox Sa Sali nitrati di farmaci attivi nei disordini ossei
JP2003519183A (ja) * 2000-01-04 2003-06-17 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 心臓および動脈の石灰化を抑制する低用量ビスホスホネートの使用
WO2008128056A1 (en) * 2004-10-08 2008-10-23 The Board Of Trustees Of The University Of Illinois Bisphosphonate compounds and methods with enhanced potency for multiple targets including fpps, ggpps, and dpps
WO2006039721A2 (en) * 2004-10-08 2006-04-13 The Board Of Trustees Of The University Of Illinois Bisphosphonate compounds and methods for bone resorption diseases, cancer, bone pain, immune disorders, and infectious diseases
EP2001486A4 (en) * 2006-03-17 2010-12-29 Univ Illinois BIPHOSPHONATE COMPOUNDS AND CORRESPONDING METHODS
US7457149B2 (en) 2006-05-05 2008-11-25 Macronix International Co., Ltd. Methods and apparatus for thermally assisted programming of a magnetic memory device
JP2010523709A (ja) * 2007-04-12 2010-07-15 ザ ボード オブ トラスティーズ オブ ザ ユニヴァーシティー オブ イリノイ Ｆｐｐｓ、ｇｇｐｐｓ及びｄｐｐｓを含む複数の標的に対して高い効能を有するビスホスホネート化合物及び方法
KR102956231B1 (ko) * 2023-10-12 2026-04-23 재단법인대구경북과학기술원 포스폰산 디페닐아민 화합물 및 이를 포함하는 페로브스카이트 태양전지

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3225469A1 (de) * 1982-07-05 1984-01-05 Schering AG, 1000 Berlin und 4709 Bergkamen Diphosphonsaeure-derivate und diese enthaltende pharmazeutische praeparate
IL77243A (en) * 1984-12-21 1996-11-14 Procter & Gamble Pharmaceutical compositions containing geminal diphosphonic acid compounds and certain such novel compounds
US4812311A (en) * 1984-12-21 1989-03-14 The Procter & Gamble Company Kit for use in the treatment of osteoporosis
EP0243173B1 (en) * 1986-04-24 1991-06-26 Fujisawa Pharmaceutical Co., Ltd. New diphosphonic acid compounds, processes for the preparation thereof and pharmaceutical composition comprising the same
EP0282309A3 (en) * 1987-03-11 1990-03-14 Yamanouchi Pharmaceutical Co. Ltd. Azole-aminomethylene bisphosphonic acid derivatives
IL86951A (en) * 1987-07-06 1996-07-23 Procter & Gamble Pharma Methylene phosphonoalkylphosphinates and pharmaceutical preparations containing them
US4990503A (en) * 1988-08-12 1991-02-05 Yamanouchi Pharmaceutical Co., Ltd. Heterocyclic bisphosphonic acid derivatives

Also Published As

Publication number Publication date
FI925617A0 (fi) 1992-12-10
EP0546548A1 (de) 1993-06-16
DK0546548T3 (da) 1997-10-13
JPH05271260A (ja) 1993-10-19
DE59208426D1 (de) 1997-06-05
AU3017392A (en) 1993-06-17
BR9204984A (pt) 1993-06-15
EP0546548B1 (de) 1997-05-02
NZ245414A (en) 1995-04-27
MX9207215A (es) 1993-06-01
FI105550B (fi) 2000-09-15
US5294608A (en) 1994-03-15
ATE152453T1 (de) 1997-05-15
RU2124519C1 (ru) 1999-01-10
CA2085171A1 (en) 1993-06-13
FI925617A7 (fi) 1993-06-13
TW222637B (enExample) 1994-04-21
KR100269544B1 (ko) 2000-10-16
ES2101012T3 (es) 1997-07-01
AU657018B2 (en) 1995-02-23
JP3377234B2 (ja) 2003-02-17

Similar Documents

Publication Publication Date Title
US5294608A (en) Guanidinoalkyl-1,1-bisphosphonic acid derivatives, process for their preparation and their use
CA1338937C (en) Process for the manufacture of novel substituted alkanediphosphonic acids
EP0769015B1 (en) Phosphonic acid compounds, their production and use
US5661174A (en) Guanidinealkyl-1,1-bisphosphonic acid derivatives, process for their preparation and their use
US4732998A (en) Bisphosphonic acids and esters
CA1336978C (en) Bisphosphonates
KR100233986B1 (ko) 신규한 메틸렌비 스포스폰산 유도체
KR20080109088A (ko) 로수바스타틴 아연 염
JP3009196B2 (ja) 抗ウイルス活性を有する薬剤、燐脂質誘導体及びその製造方法
CA2511753C (en) Phospholipid derivatives
US6479472B1 (en) Methods of using therapeutic phospholipid derivatives
JPS6325582B2 (enExample)
EP0053584B1 (en) Raceme sulpiride resolution process
AU665090B2 (en) Pharmaceutical compositions containing amidines and novel amidines
JPH05213980A (ja) 抗新生物作用を有する薬剤、オクタデシル−［２−（ｎ−メチルピペリジノ）−エチル−ホスフェートの製造及び精製法及び薬剤の製法
US5177257A (en) Benzocycloalkenecarboxylic acid and process for its preparation
JPH06506452A (ja) ｇｅｍ−二リン酸のアミノアシル誘導体、その製造方法およびこの誘導体を含む薬剤学的組成物
JPH04264091A (ja) 新規ベンゾヘテロ環アルキルアミノアルカンジホスホン酸
HUT73660A (en) Imidobisphosphoric acids, process for producing them, and use of them
KR20140069378A (ko) 로수바스타틴 아연 염

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed